ALOPECIA AREATA
Clinical trials for ALOPECIA AREATA explained in plain language.
Never miss a new study
Get alerted when new ALOPECIA AREATA trials appear
Sign up with your email to follow new studies for ALOPECIA AREATA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill could regrow hair in severe alopecia – trial begins
Disease control Not yet recruitingThis study tests a drug called deuruxolitinib in Japanese adults aged 18-65 with severe alopecia areata, an autoimmune condition causing significant scalp hair loss. Participants must have at least 50% hair loss. The trial measures how well the drug regrows hair and how satisfied…
Matched conditions: ALOPECIA AREATA
Phase: PHASE3 • Sponsor: Sun Pharma Japan Limited • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Hair loss showdown: can a chemo drug gel beat minoxidil for alopecia areata?
Disease control Not yet recruitingThis study tests whether a gel containing methotrexate, an immune-suppressing drug, can regrow hair in people with localized alopecia areata better than minoxidil spray. About 268 adults with less than 25% scalp hair loss will apply one of the two treatments twice daily for 24 we…
Matched conditions: ALOPECIA AREATA
Phase: PHASE4 • Sponsor: Jinnah Postgraduate Medical Centre • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New hope for hair loss: vitamin d cream vs steroid shots
Disease control Not yet recruitingThis study tests whether a vitamin D-based cream (calcipotriol) works as well as steroid injections for regrowing hair in people with patchy alopecia areata. Sixty adults with less than half their scalp affected will use one of the two treatments for 12 weeks. The goal is to see …
Matched conditions: ALOPECIA AREATA
Phase: PHASE4 • Sponsor: Hayat Abad Medical Complex, Peshawar • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Hair loss drug showdown: tofacitinib vs methotrexate in new trial
Disease control Not yet recruitingThis study compares two oral medications—tofacitinib and methotrexate—for treating severe alopecia areata, an autoimmune condition causing hair loss. 78 adults aged 18-60 with severe scalp or total body hair loss will take one of the drugs for 12 weeks. The main goal is to see wh…
Matched conditions: ALOPECIA AREATA
Phase: PHASE4 • Sponsor: Hayat Abad Medical Complex, Peshawar • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Italian skin disease registry aims to map treatment journeys for 20,000 patients
Knowledge-focused Not yet recruitingThis study will collect existing medical records from about 20,000 people aged 12 and older in Italy who have one of five inflammatory skin conditions: psoriasis, atopic dermatitis, vitiligo, alopecia areata, or hidradenitis suppurativa. Researchers want to describe who gets thes…
Matched conditions: ALOPECIA AREATA
Sponsor: Fondazione ISIDE • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:11 UTC